Kristina Daniunaite
Vilnius, VL LT10257, Lithuania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effects of Short-Term Treatment with α-Lipoic Acid on Neuropathic Pain and Biomarkers of DNA Damage in Patients with Diabetes Mellitus.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 26, 2024
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases.
Journal: International journal of molecular sciences
Published: October 06, 2022
Multiomics Analysis of Neuroblastoma Cells Reveals a Diversity of Malignant Transformations.
Journal: Frontiers in cell and developmental biology
Published: June 18, 2021
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence.
Journal: International journal of molecular sciences
Published: April 06, 2021
Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.
Journal: Scientific reports
Published: June 12, 2020
The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival.
Journal: Medicina (Kaunas, Lithuania)
Published: January 06, 2020
Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.
Journal: Clinical epigenetics
Published: March 26, 2019
Epigenomic technologies for deciphering circulating tumor DNA.
Journal: Current opinion in biotechnology
Published: May 01, 2018
Clinical significance of miRNA host gene promoter methylation in prostate cancer.
Journal: Human molecular genetics
Published: December 03, 2016
Decreased expression of MT1E is a potential biomarker of prostate cancer progression.
Journal: Oncotarget
Published: November 15, 2016
Last Updated: 09/26/2026